HDL in atherosclerosis: actor or bystander?
Data up to Jan 2025
Total Citations Per Year
Abstract
References (56)
Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
1993 • 28,274 citations
Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
2001 • 24,089 citations
High density lipoprotein as a protective factor against coronary heart disease
1977 • 5,019 citations
Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol
1999 • 3,464 citations
High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.
1989 • 3,169 citations
Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
1988 • 2,276 citations
Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency
1999 • 1,708 citations
The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease
1999 • 1,527 citations
Molecular physiology of reverse cholesterol transport.
1995 • 1,452 citations
Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1
1999 • 1,441 citations
Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment.
1992 • 1,341 citations
THE TROMSØHEART-STUDY
1977 • 1,212 citations
A Prospective Study of Cholesterol, Apolipoproteins, and the Risk of Myocardial Infarction
1991 • 1,184 citations
Cholesterol and mortality. 30 years of follow-up from the Framingham study
1987 • 981 citations
Recent Trends in Acute Coronary Heart Disease — Mortality, Morbidity, Medical Care, and Risk Factors
1996 • 705 citations
Early incorporation of cell-derived cholesterol into pre-.beta.-migrating high-density lipoprotein
1988 • 643 citations
Cholesterol and Mortality
1987 • 579 citations
Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis
1987 • 477 citations
The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of NHLBI Type II Coronary Intervention Study.
1984 • 449 citations
Association of Cholesteryl Ester Transfer Protein– Taq IB Polymorphism With Variations in Lipoprotein Subclasses and Coronary Heart Disease Risk
2000 • 390 citations
The Münster Heart Study (PROCAM). Results of follow-up at 8 years.
1998 • 358 citations
Apolipoprotein A-I containing lipoproteins in coronary artery disease
1987 • 330 citations
HDL-cholesterol as a marker of coronary heart disease risk: the Québec cardiovascular study
2000 • 319 citations
NIH Consensus conference. Triglyceride, high-density lipoprotein, and coronary heart disease. NIH Consensus Development Panel on Triglyceride, High-Density Lipoprotein, and Coronary Heart Disease
1993 • 304 citations
HIGH DENSITY LIPOPROTEIN CHOLESTEROL AND INCIDENCE OF CORONARY HEART DISEASE THE ISRAELI ISCHEMIC HEART DISEASE STUDY
1979 • 271 citations
Relation of High TG–Low HDL Cholesterol and LDL Cholesterol to the Incidence of Ischemic Heart Disease
1997 • 262 citations
A case-control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease. The ECTIM Study.
1992 • 238 citations
Comparison of effects on low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with rosuvastatin versus atorvastatin in patients with type IIa or IIb hypercholesterolemia
2002 • 234 citations
Action of Atorvastatin in Combined Hyperlipidemia
2000 • 231 citations
Decreased HDL2 and HDL3 cholesterol, Apo A-I and Apo A-II, and increased risk of myocardial infarction.
1992 • 229 citations
Two-dimensional electrophoresis of plasma lipoproteins: Recognition of new apo A-I-containing subpopulations
1993 • 229 citations
High density and low density lipoprotein subfractions in survivors of myocardial infarction and in control subjects
1982 • 221 citations
Altered particle size distribution of apolipoprotein A-I-containing lipoproteins in subjects with coronary artery disease
1991 • 207 citations
Effect of rosuvastatin on low-density lipoprotein cholesterol in patients with hypercholesterolemia
2001 • 194 citations
Distribution of ApoA-I–Containing HDL Subpopulations in Patients With Coronary Heart Disease
2000 • 193 citations
Cholesteryl Ester Transfer Protein Taq I B2B2 Genotype Is Associated With Higher HDL Cholesterol Levels and Lower Risk of Coronary Heart Disease End Points in Men With HDL Deficiency
2002 • 154 citations
Physiological role and clinical relevance of high-density lipoprotein subclasses
1994 • 153 citations
Comparative effects of rosuvastatin and atorvastatin across their dose ranges in patients with hypercholesterolemia and without active arterial disease
2003 • 138 citations
Novel mutations in the gene encoding ATP-binding cassette 1 in four Tangier disease kindreds
2000 • 134 citations
Regulation of the concentration of pre.beta. high-density lipoprotein in normal plasma by cell membranes and lecithin-cholesterol acyltransferase activity
1992 • 110 citations
Comparing the effects of five different statins on the HDL subpopulation profiles of coronary heart disease patients
2002 • 110 citations
High density lipoprotein cholesterol and myocardial infarction or sudden coronary death: a prospective case-control study in middle-aged men of the Oslo study.
1979 • 99 citations
Twelve-year incidence of coronary heart disease in middle-aged adults during the era of hypertensive therapy: the framingham offspring study
1991 • 98 citations
Associations of the HDL2 and HDL3 cholesterol subfractions with the development of ischemic heart disease in British men. The Caerphilly and Speedwell Collaborative Heart Disease Studies.
1994 • 98 citations
Subpopulations of high density lipoproteins in homozygous and heterozygous Tangier disease
2001 • 93 citations
Different reactivities of high density lipoprotein2 subfractions with hepatic lipase.
1992 • 92 citations
Cellular cholesterol efflux in heterozygotes for Tangier disease is markedly reduced and correlates with high density lipoprotein cholesterol concentration and particle size
2000 • 76 citations
Association of low HDL and HDL2 cholesterol with coronary heart disease in noninsulin-dependent diabetics.
1985 • 66 citations
Association of cholesterol concentrations in low-density lipoprotein, high-density lipoprotein, and high-density lipoprotein subfractions, and of apolipoproteins AI and AII, with coronary stenosis and left ventricular function.
1987 • 51 citations
Concentrations of apolipoprotein A-I-containing particles in patients with hypoalphalipoproteinemia.
1994 • 38 citations
Normolipidemic Subjects With Low HDL Cholesterol Levels Have Altered HDL Subpopulations
1997 • 36 citations
Rosuvastatin (20, 40 and 80 MG) reduces LDL-C, raises HDL-C and achieves treatment goals more effectively than atorvastatin (20, 40 and 80 MG) in patients with heterozygous familial hypercholesterolaemia
2001 • 20 citations
Rosuvastatin significantly improves lipid parameters and ability to achieve low-density lipoprotein cholesterol goals compared with pravastatin
2003 • 7 citations
Rosuvastatin produces significantly greater reductions in low-density lipoprotein cholesterol and more patients achieve treatment goals compared with simvastatin
2003 • 6 citations
Rosuvastatin is more effective than atorvastatin in modifying lipid profiles and achieving national cholesterol education program adult treatment panel III LDL-cholesterol goals
2002 • 5 citations
Effects of rosuvastatin alone and combined with extended-release niacin on Apo B- and Apo A-containing lipoproteins and triglycerides in atherogenic dyslipidemia
2002 • 2 citations